The SMAC mimetic birinapant alleviates lipopolysaccharide-induced acute lung injury by inhibiting MAPK signaling

In conclusion, the results proved that birinapant protected against LPS-induced ALI through inhibiting MAPK activation and K48-linked ubiquitination of TRAF3 in alveolar macrophages.PMID:37913914 | DOI:10.1016/j.imlet.2023.10.008
Source: Immunology Letters - Category: Allergy & Immunology Authors: Source Type: research